Jim Cramer explains why shares of ServiceNow are a buy
‘Mad Money’ host Jim Cramer breaks down shares of cloud computing company ServiceNow following its first-quarter earnings results.
Read More »
Fed Chair Jay Powell can navigate a soft landing, says Jim Cramer
‘Mad Money’ host Jim Cramer joins ‘Squawk Box’ to break down markets ahead of the open.
Read More »
LIVE: Market Matters with CNBC’s Bob Pisani — 4/28/22
Watch CNBC’s senior stocks correspondent Bob Pisani as he answers all your markets and investing questions. Stocks rose Thursday, following a strong earnings report from Meta Platforms, as the market sought to recover from this month’s sell-off. A slew of…
Read More »
U.S. GDP makes surprising 1.4% drop during first quarter
CNBC’s Rick Santelli joins ‘Squawk Box’ to break down the initial first-quarter U.S. GDP and weekly jobless claims data.
Read More »
LIVE: Biden speaks in support of Ukrainians defending their country against Russia’s war — 4/28/22
President Biden delivers remarks in support for Ukrainians defending their freedom against Russia’s brutal war in their country. The White House is preparing to send a request to Congress for additional Ukraine aid as early as Thursday, administration officials confirmed…
Read More »
Elon Musk faces backlash after targeting Twitter lawyer: Report
Alan Guarino, Korn Ferry vice chairman, Tsedal Neeley, Harvard Business School professor, and CNBC’s Jon Fortt joins CNBC’s ‘Squawk Box’ to discuss Elon Musk’s recent tweet criticizing Twitter’s top lawyer.
Read More »
Ford CFO John Lawler: We are not seeing any signs of easing demand
CNBC’s Phil LeBeau sits down with Ford CFO John Lawler to break down the company’s first-quarter earnings results and the company’s expectations for the second quarter.
Read More »
Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results
Eli Lilly CEO David Ricks joins CNBC’s Meg Tirrell and the ‘Squawk Box’ team to break down the company’s latest earnings report and its clinical trial results for weight-loss drug tirzepatide.
Read More »